These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23774940)

  • 21. Cytochrome P450 2B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda.
    Penzak SR; Kabuye G; Mugyenyi P; Mbamanya F; Natarajan V; Alfaro RM; Kityo C; Formentini E; Masur H
    HIV Med; 2007 Mar; 8(2):86-91. PubMed ID: 17352764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients.
    Rotger M; Colombo S; Furrer H; Bleiber G; Buclin T; Lee BL; Keiser O; Biollaz J; Décosterd L; Telenti A;
    Pharmacogenet Genomics; 2005 Jan; 15(1):1-5. PubMed ID: 15864119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection.
    Pollard RB; Robinson P; Dransfield K
    Clin Ther; 1998; 20(6):1071-92. PubMed ID: 9916603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians.
    Brown KC; Hosseinipour MC; Hoskins JM; Thirumaran RK; Tien HC; Weigel R; Tauzie J; Shumba I; Lamba JK; Schuetz EG; McLeod HL; Kashuba AD; Corbett AH
    Pharmacogenomics; 2012 Jan; 13(1):113-21. PubMed ID: 22111602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of human leukocyte antigen alleles and nevirapine hypersensitivity in a Malawian HIV-infected population.
    Carr DF; Chaponda M; Jorgensen AL; Castro EC; van Oosterhout JJ; Khoo SH; Lalloo DG; Heyderman RS; Alfirevic A; Pirmohamed M
    Clin Infect Dis; 2013 May; 56(9):1330-9. PubMed ID: 23362284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of combined IL-13/IL-4R signaling pathway gene polymorphism with Stevens-Johnson syndrome accompanied by ocular surface complications.
    Ueta M; Sotozono C; Inatomi T; Kojima K; Hamuro J; Kinoshita S
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1809-13. PubMed ID: 18263811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity.
    Ritchie MD; Haas DW; Motsinger AA; Donahue JP; Erdem H; Raffanti S; Rebeiro P; George AL; Kim RB; Haines JL; Sterling TR
    Clin Infect Dis; 2006 Sep; 43(6):779-82. PubMed ID: 16912956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai women.
    Chantarangsu S; Cressey TR; Mahasirimongkol S; Capparelli E; Tawon Y; Ngo-Giang-Huong N; Jourdain G; Lallemant M; Chantratita W
    J Antimicrob Chemother; 2009 Dec; 64(6):1265-73. PubMed ID: 19812066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring the overall genetic component of nevirapine pharmacokinetics and the role of selected polymorphisms: towards addressing the missing heritability in pharmacogenetic phenotypes?
    Micheli JE; Chinn LW; Shugarts SB; Patel A; Martin JN; Bangsberg DR; Kroetz DL
    Pharmacogenet Genomics; 2013 Nov; 23(11):591-6. PubMed ID: 23982262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaboration.
    Haas DW; Bartlett JA; Andersen JW; Sanne I; Wilkinson GR; Hinkle J; Rousseau F; Ingram CD; Shaw A; Lederman MM; Kim RB;
    Clin Infect Dis; 2006 Sep; 43(6):783-6. PubMed ID: 16912957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of HLA-A*02:06:01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing.
    Nakatani K; Ueta M; Khor SS; Hitomi Y; Okudaira Y; Masuya A; Wada Y; Sotozono C; Kinoshita S; Inoko H; Tokunaga K
    Sci Rep; 2019 Nov; 9(1):16240. PubMed ID: 31700100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic association of IFN-γ +874T/A polymorphism in Mexican patients with drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Charli-Joseph Y; Lima G; Ramos-Bello D; Aguilar D; Orozco-Topete R; Llorente L
    Arch Dermatol Res; 2013 May; 305(4):353-7. PubMed ID: 23224615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stevens-Johnson syndrome in an HIV-infected patient.
    Blitz M; Spivack E; Kerpel SM; Freedman PD
    AIDS Read; 1999; 9(3):184-5, 190. PubMed ID: 12728904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigating the association of Lamotrigine and Phenytoin-induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis with HLA-B*1502 in Iranian population.
    Sabourirad S; Mortezaee R; Mojarad M; Eslahi A; Shahrokhi Y; Kiafar B; Jarahi L; Afkhami Ardakani S; Farrokhi S
    Exp Dermatol; 2021 Feb; 30(2):284-287. PubMed ID: 33217035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stevens Johnson Syndrome and Toxic Epidermal Necrolysis: Maternal and Foetal Outcomes in Twenty-Two Consecutive Pregnant HIV Infected Women.
    Knight L; Todd G; Muloiwa R; Matjila M; Lehloenya RJ
    PLoS One; 2015; 10(8):e0135501. PubMed ID: 26267659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of CYP2C9*3 with phenytoin-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis.
    Wu X; Liu W; Zhou W
    J Clin Pharm Ther; 2018 Jun; 43(3):408-413. PubMed ID: 29274302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
    Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W
    Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stevens-Johnson syndrome and HIV in children in Swaziland.
    Dziuban EJ; Hughey AB; Stewart DA; Blank DA; Kochelani D; Draper HR; Schutze GE
    Pediatr Infect Dis J; 2013 Dec; 32(12):1354-8. PubMed ID: 23743542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Stevens-Johnson syndrome and toxic epidermal necrolysis in a teaching hospital in Lomé, Togo: retrospective study of 89 cases].
    Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Tchangaï-Walla K; Pitché P
    Med Trop (Mars); 2010 Jun; 70(3):255-8. PubMed ID: 20734593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population pharmacokinetic-pharmacogenetic study of nevirapine in HIV-infected Cambodian patients.
    Chou M; Bertrand J; Segeral O; Verstuyft C; Borand L; Comets E; Le Tiec C; Becquemont L; Ouk V; Mentre F; Taburet AM
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4432-9. PubMed ID: 20696882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.